ABSTRACT Background Elexacaftor/tezacaftor/ivacaftor (ETI) is a Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) therapy that improves pulmonary function and chronic rhinosinusitis (CRS) in cystic fibrosis (CF) adults with at least one copy of the F508del CFTR mutation.
Margaux Petitjean+16 more
wiley +1 more source
Cardiometabolic Disease Risk Factors and Lifestyle Behaviors Among Adolescents: A Latent Class Analysis. [PDF]
de Faria FR+6 more
europepmc +1 more source
Progress in research on osteoporosis secondary to SARS‐CoV‐2 infection
This review explores the potential mechanisms, complications, risk factors, and future research directions related to osteoporosis secondary to SARS‐CoV‐2 infection. Key mechanisms include an imbalance between osteoclast and osteoblast activity driven by direct viral effects on bone, inflammation, hypoxia, dysregulation of noncoding RNAs, and metabolic
Jinlong Wang+5 more
wiley +1 more source
Mapping evidence on educational interventions for adolescents with cancer: a scoping review protocol. [PDF]
Kyei-Dompim J+3 more
europepmc +1 more source
Nutritional status, psychological status and quality of life of adolescents in selected childcare institutions in the Galle district of Sri Lanka. [PDF]
De Zilva L, De Zoysa E.
europepmc +1 more source
A mixed methods exploration of the experiences of physical activity providers in supporting children and adolescents with type 1 diabetes in the UK. [PDF]
Ngamy T+9 more
europepmc +1 more source
The use of valve prostheses in congenital heart diseases in children and adolescents
Kazumi Taguchi+5 more
openalex +1 more source
A harsher reality for adolescents with depression on social media. [PDF]
Janssen LHC+3 more
europepmc +1 more source